Ningbo Severe Mental Disorders Cohort
Conditions: Severe Mental Disorder; Schizophrenia; Bipolar Disorder; Schizo-Affective Psychosis; Paranoid Psychoses; Mental Retardation; Epileptic Psychosis Interventions: Other: Patient with severe mental disorder without intervention Sponsors: Ningbo University; The Affiliated Kangning Hospital of Ningbo University Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 17, 2024 Category: Research Source Type: clinical trials
Effect of Different Peep Values on Gastric Residual Volume
Conditions: Respiratory Aspiration of Gastric Content Interventions: Procedure: PEEP 0; Procedure: PEEP 4; Procedure: PEEP 8 Sponsors: Ankara City Hospital Bilkent Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 17, 2024 Category: Research Source Type: clinical trials
Serplulimab Combined With Bevacizumab Biosimilar and HAIC in Advanced Hepatocellular Carcinoma (HCC) Patients
Conditions: Advanced Hepatocellular Carcinoma Interventions: Drug: HAIC+Serplulimab （HLX10）+ Bevacizumab Biosimilar（HLX04） Sponsors: Tianjin Medical University Cancer Institute and Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 17, 2024 Category: Research Source Type: clinical trials
First-line Treatment for Unresectable Locally Advanced Distal Cholangiocarcinoma Combining Radiotherapy and HAIC
Conditions: Intrahepatic Cholangiocarcinoma Interventions: Radiation: Radiotherapy; Drug: HAIC (GEMOX); Drug: Chemotherapy Sponsors: Shandong Cancer Hospital and Institute Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 17, 2024 Category: Research Source Type: clinical trials
the Prevention of Bone Marrow Suppression Caused by Chemotherapy in Advanced NSCLC With Trilaciclib
Conditions: Non-small Cell Lung Cancer Interventions: Drug: Trilaciclib Sponsors: Henan Cancer Hospital; Jiangsu Simcere Pharmaceutical Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 17, 2024 Category: Research Source Type: clinical trials
A Real World Study of Equecabtagene Autoleucel in Subjects With Relapsed and Refractory Multiple Myeloma.
Conditions: Relapsed/Refractory Multiple Myeloma Interventions: Drug: Equecabtagene Autoleucel Sponsors: Peking University People ' s Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 17, 2024 Category: Research Source Type: clinical trials
Immunometabolism of Machine Perfusion Strategies
Conditions: Liver Transplantation Interventions: Device: Machine Perfusion Sponsors: King ' s College Hospital NHS Trust; King ' s College London Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 17, 2024 Category: Research Source Type: clinical trials
Norepinephrine Infusion Combined With Goal-directed Fluid Therapy in Patients Undergoing Kidney Transplantations
Conditions: Delayed Graft Function; End Stage Renal Disease; Kidney Transplantation Interventions: Drug: Goal-Directed Fluid Therapy (GDFT); Drug: Regular Fluid Therapy Sponsors: RenJi Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 16, 2024 Category: Research Source Type: clinical trials
Exosome microRNAs as Potential Biomarkers of Metabolic Bone Disease of Prematurity
Conditions: Exosomes; Newborn; Bone Diseases, Metabolic Sponsors: Hunan Children ' s Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 16, 2024 Category: Research Source Type: clinical trials
Diagnosis of Epithelial Ovarian Cancer Using Ovarian Cancer Score (OCS) Test
Conditions: Epithelial Ovarian Cancer; Adnexal Mass Sponsors: Chongqing University Cancer Hospital; Zhejiang Cancer Hospital; Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University; The First Affiliated Hospital of Zhengzhou University; 3D Medicines Corporation Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 16, 2024 Category: Research Source Type: clinical trials
Optimization of Atopic Dermatitis Treatment That Requires Second-line Systemic Therapy Through Predictive Models
Conditions: Atopic Dermatitis Interventions: Drug: Second-line systemic treatment; Other: Folllow-up of second-line systemic treatment already started Sponsors: Instituto de Investigaci ón Hospital Universitario La Paz Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 16, 2024 Category: Research Source Type: clinical trials
Clinical and Genetic Findings in Patients With PRPF31-associated Retinitis Pigmentosa
Conditions: Retinitis Pigmentosa Sponsors: University Hospital Tuebingen Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 16, 2024 Category: Research Source Type: clinical trials
Unraveling the Pathogenesis of Pruritus in Intrahepatic Cholestasis of Pregnancy
Conditions: Intrahepatic Cholestasis of Pregnancy Sponsors: Peking University; Peking University Third Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 16, 2024 Category: Research Source Type: clinical trials
Emotion and Symptom-Focused Engagement (EASE) for Caregivers
Conditions: Trauma and Stressor Related Disorders; Pediatric Cancer; Caregiver Burden Interventions: Behavioral: EASE Sponsors: University Health Network, Toronto; The Hospital for Sick Children; Canadian Institutes of Health Research (CIHR) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 16, 2024 Category: Research Source Type: clinical trials
Cadonilimab Combined With Chemotherapy as First or Second Line Treatment in Recurrent or Metastatic Triple Negative Breast Cancer
Conditions: Triple-negative Breast Cancer; Cadonilimab Interventions: Drug: Cadonilimab Sponsors: Wuhan Union Hospital, China Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 16, 2024 Category: Research Source Type: clinical trials
